2m 2m 2m 2m 2m 2m 2m
United Therapeut (UTHR)
NASDAQ
$512.95-$3.36 (-0.65%)
Price as of Aug 04, 2026 9:35 AM EDT- $21.9BMarket Cap
- 76.43%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
United Therapeut (UTHR)
$512.95-$3.36 (-0.65%)
UTHR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $516.31 | ||
Change | -$1.40 (-0.27%) | ||
Open | $516.29 | ||
High | $519.74 | ||
Low | $514.01 | ||
Previous Close | $517.71 | ||
Volume | 427,627 | ||
30-Day Average Volume | 400,496 | ||
1-Week Change | -2.20% | ||
1-Month Change | -7.12% | ||
1-Year Change | 76.43% | ||
3-Year Change | 122.67% | ||
5-Year Change | 185.79% | ||
Fundamentals | |||
Shares Outstanding | 42.4M | ||
Total Assets | $6.7B | ||
Market Cap | $21.9B | ||
Enterprise Value | $20.8B | ||
Period: QTR TTM FY | |||
Revenue | $781.5M | ||
Net Income | $274.9M | ||
Free Cash Flow | $362.5M | ||
EBIT | $318.3M | ||
EBITDA | $340.9M | ||
Net Working Capital | $2.3B | ||
EPS | $5.82 | ||
Enterprise Value/EBITDA | 61 | ||
Enterprise Value/Revenue | 27 | ||
P/B | 4 | ||
P/E | 89 | ||
PEG | -4 | ||
Price/Free Cash Flow | 60 | ||
Price/Operating Cash Flow | 47 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue